Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The FTSE 100 fell for a third consecutive session on Wednesday, reaching a three-week low and ending September 2% lower. The decline followed a 0.4% monthly drop in August, marking two consecutive months of losses, although the index still gained 1.1% over the third quarter. That quarterly advance was supported by a 5.
FTSE 100 was little changed Tuesday: declines in pharma, consumer and banking were offset by gains in commodity-related shares. UK retail sales rose 0.7% in August, below the 1.6% 12-month average.
European trading shows S&P 500, Nasdaq 100, Dow and Russell futures higher, while the dollar index falls and EUR/USD, GBP/USD and WTI crude edge up.
WTI crude is down 2.17% to 81.46 in the European session, while S&P 500 futures are up 0.14% and Nasdaq 100 futures are down 0.08%.
AstraZeneca stock price drops
AstraZeneca Plc (NASDAQ: AZN ) on Monday posted mixed second-quarter 2026 results, beating Wall Street’s earnings estimates while falling short on revenue. The drugmaker also reported disappointing late-stage trial results for two experimental therapies, including a Phase 3 study of Ultomiris. AstraZeneca Beats Earning